CVS Health Corporation (NYSE: CVS) Rating Reiterated at Credit Suisse Group AG

Analysts at Credit Suisse Group AG reiterated a Buy rating on shares of CVS Health Corporation (NYSE: CVS) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. Credit Suisse Group AG currently has a rating of Buy on the shares. The one-year price target of $111.07 is above the opening price of $89.50, resulting a fair amount of other analysts to report on the company recently. Looking back over the last year, CVS Health Corporation stock has a high of $106.67. Usually, after analysts publish a “reiterated rating” report on a stock, they will later issue other revisions, such as a price target change.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Yesterday CVS Health Corporation (NYSE: CVS) shares last traded at $89.99, which is a spike of $0.82 from the previous closing price. Opening at $89.50, they ranged from $89.50 and $90.29 throughout the day.

CVS Health Corporation (NYSE: CVS) now has a market cap of 95.95B.

5,465,065 shares traded hands yesterday, 84 percent higher than the average, out of a total float 1,064,434,000. Heavy volume accumulation by institutional investors may be in the near future as the combination of substantial gains in trading volume and price appreciation can be indicative components.

However, a single day of high volume buy side trading is not enough to affirm a trend. So market traders will continue to watch for institutional sponsorship as a cue that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts that investigate thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

With that in mind, CVS Health Corporation (NYSE: CVS) now has a 50-day MA of $94.64 and 200-day MA of $97.97. It has traded in a 52-week range between $86.50 – 106.67 and today’s last price is 0.16% lower than the 52 week high of $106.67.

Earnings growth is a crucial factor to research when buying stocks and investors identify companies that have increased their earnings at least 25% or more for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *